| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Arrhythmias, Cardiac | 30 | 2026 | 484 | 6.490 |
Why?
|
| Tachycardia, Ventricular | 17 | 2026 | 255 | 6.040 |
Why?
|
| Long QT Syndrome | 8 | 2023 | 86 | 2.910 |
Why?
|
| Electrocardiography | 29 | 2026 | 974 | 2.520 |
Why?
|
| Defibrillators, Implantable | 8 | 2023 | 215 | 2.090 |
Why?
|
| Anti-Arrhythmia Agents | 19 | 2024 | 228 | 1.880 |
Why?
|
| Tachycardia, Supraventricular | 9 | 2024 | 107 | 1.830 |
Why?
|
| Heart Arrest | 4 | 2022 | 373 | 1.460 |
Why?
|
| Cardiomyopathies | 6 | 2026 | 515 | 1.330 |
Why?
|
| Heart Defects, Congenital | 16 | 2026 | 1875 | 1.320 |
Why?
|
| Wolff-Parkinson-White Syndrome | 5 | 2024 | 74 | 1.290 |
Why?
|
| Atrial Fibrillation | 6 | 2024 | 733 | 1.260 |
Why?
|
| NAV1.5 Voltage-Gated Sodium Channel | 2 | 2023 | 43 | 1.250 |
Why?
|
| Death, Sudden, Cardiac | 8 | 2022 | 273 | 1.200 |
Why?
|
| Exercise Test | 4 | 2019 | 234 | 1.190 |
Why?
|
| Ryanodine Receptor Calcium Release Channel | 5 | 2025 | 241 | 1.110 |
Why?
|
| Child | 61 | 2026 | 26165 | 1.110 |
Why?
|
| Heart Rate | 9 | 2026 | 574 | 1.100 |
Why?
|
| Vitamin B Complex | 2 | 2023 | 35 | 0.970 |
Why?
|
| Adolescent | 47 | 2026 | 20754 | 0.960 |
Why?
|
| Cardiomyopathy, Hypertrophic | 7 | 2021 | 161 | 0.950 |
Why?
|
| Echocardiography | 9 | 2021 | 1125 | 0.910 |
Why?
|
| Sotalol | 5 | 2023 | 33 | 0.870 |
Why?
|
| Pacemaker, Artificial | 6 | 2025 | 194 | 0.840 |
Why?
|
| Child, Preschool | 35 | 2025 | 14985 | 0.840 |
Why?
|
| Infant | 32 | 2025 | 13269 | 0.780 |
Why?
|
| Retrospective Studies | 42 | 2025 | 17614 | 0.750 |
Why?
|
| Humans | 97 | 2026 | 130422 | 0.750 |
Why?
|
| Cardiomyopathy, Dilated | 3 | 2025 | 198 | 0.740 |
Why?
|
| Neurodevelopmental Disorders | 2 | 2025 | 621 | 0.740 |
Why?
|
| Male | 64 | 2026 | 64527 | 0.720 |
Why?
|
| Exosome Multienzyme Ribonuclease Complex | 1 | 2021 | 9 | 0.690 |
Why?
|
| Ataxia | 1 | 2022 | 157 | 0.680 |
Why?
|
| Catheter Ablation | 8 | 2022 | 320 | 0.680 |
Why?
|
| Heart Conduction System | 4 | 2017 | 161 | 0.670 |
Why?
|
| Female | 62 | 2026 | 70285 | 0.670 |
Why?
|
| Cardiology | 7 | 2021 | 510 | 0.630 |
Why?
|
| Mutation | 8 | 2025 | 6131 | 0.630 |
Why?
|
| Genetic Predisposition to Disease | 6 | 2025 | 3425 | 0.620 |
Why?
|
| Tomography, Emission-Computed, Single-Photon | 1 | 2019 | 95 | 0.610 |
Why?
|
| Atrioventricular Block | 5 | 2025 | 45 | 0.610 |
Why?
|
| Coronary Aneurysm | 1 | 2019 | 34 | 0.610 |
Why?
|
| Phenotype | 7 | 2025 | 4474 | 0.600 |
Why?
|
| Intellectual Disability | 2 | 2025 | 1080 | 0.590 |
Why?
|
| Exercise Tolerance | 1 | 2019 | 90 | 0.590 |
Why?
|
| Genetic Association Studies | 3 | 2021 | 823 | 0.580 |
Why?
|
| Mucocutaneous Lymph Node Syndrome | 1 | 2019 | 77 | 0.580 |
Why?
|
| Antigens, Neoplasm | 1 | 2021 | 398 | 0.570 |
Why?
|
| Seizures | 2 | 2024 | 876 | 0.560 |
Why?
|
| Cardiac Pacing, Artificial | 5 | 2026 | 132 | 0.550 |
Why?
|
| Electrophysiologic Techniques, Cardiac | 5 | 2024 | 72 | 0.550 |
Why?
|
| Heart Failure | 5 | 2023 | 2314 | 0.520 |
Why?
|
| RNA-Binding Proteins | 1 | 2021 | 541 | 0.520 |
Why?
|
| Diagnosis, Differential | 4 | 2026 | 1889 | 0.490 |
Why?
|
| Sick Sinus Syndrome | 1 | 2015 | 16 | 0.450 |
Why?
|
| Tachycardia, Atrioventricular Nodal Reentry | 2 | 2022 | 32 | 0.450 |
Why?
|
| Follow-Up Studies | 13 | 2019 | 5186 | 0.450 |
Why?
|
| Muscular Dystrophy, Duchenne | 1 | 2016 | 68 | 0.450 |
Why?
|
| Syncope | 1 | 2015 | 53 | 0.450 |
Why?
|
| Circadian Rhythm | 1 | 2017 | 315 | 0.440 |
Why?
|
| Treatment Outcome | 22 | 2026 | 12860 | 0.430 |
Why?
|
| Electric Countershock | 4 | 2021 | 74 | 0.420 |
Why?
|
| Radiation Dosage | 2 | 2013 | 136 | 0.410 |
Why?
|
| Young Adult | 18 | 2026 | 9995 | 0.400 |
Why?
|
| Risk Factors | 15 | 2025 | 10942 | 0.400 |
Why?
|
| Flecainide | 3 | 2021 | 21 | 0.400 |
Why?
|
| Propranolol | 3 | 2022 | 111 | 0.390 |
Why?
|
| Sudden Infant Death | 1 | 2013 | 37 | 0.390 |
Why?
|
| Myocytes, Cardiac | 4 | 2024 | 674 | 0.390 |
Why?
|
| Ventricular Fibrillation | 1 | 2013 | 53 | 0.380 |
Why?
|
| Ventricular Function, Left | 3 | 2026 | 537 | 0.380 |
Why?
|
| Myocarditis | 1 | 2013 | 132 | 0.370 |
Why?
|
| Heart | 3 | 2015 | 661 | 0.370 |
Why?
|
| Genetic Testing | 4 | 2025 | 1100 | 0.360 |
Why?
|
| Body Surface Potential Mapping | 2 | 2012 | 17 | 0.360 |
Why?
|
| Fluoroscopy | 2 | 2013 | 101 | 0.350 |
Why?
|
| Pedigree | 4 | 2024 | 1683 | 0.340 |
Why?
|
| Cardiac Imaging Techniques | 2 | 2020 | 27 | 0.330 |
Why?
|
| Endosonography | 1 | 2010 | 76 | 0.320 |
Why?
|
| Heart Neoplasms | 1 | 2011 | 107 | 0.320 |
Why?
|
| Hospitalization | 4 | 2022 | 1927 | 0.320 |
Why?
|
| Patient Care Management | 2 | 2020 | 61 | 0.320 |
Why?
|
| Cardiac Resynchronization Therapy | 2 | 2026 | 47 | 0.310 |
Why?
|
| Incidence | 10 | 2024 | 3330 | 0.310 |
Why?
|
| Infant, Newborn | 15 | 2021 | 8493 | 0.300 |
Why?
|
| Inpatients | 1 | 2013 | 550 | 0.300 |
Why?
|
| United States | 18 | 2025 | 11827 | 0.290 |
Why?
|
| Tachycardia, Ectopic Atrial | 1 | 2008 | 7 | 0.280 |
Why?
|
| Electroencephalography | 3 | 2025 | 853 | 0.280 |
Why?
|
| Tachycardia | 2 | 2026 | 70 | 0.280 |
Why?
|
| Predictive Value of Tests | 7 | 2020 | 2298 | 0.280 |
Why?
|
| Exome | 4 | 2022 | 1075 | 0.270 |
Why?
|
| Rheumatic Fever | 1 | 2007 | 20 | 0.260 |
Why?
|
| Age of Onset | 3 | 2025 | 598 | 0.260 |
Why?
|
| Time Factors | 12 | 2026 | 6190 | 0.260 |
Why?
|
| Epilepsy | 2 | 2025 | 871 | 0.260 |
Why?
|
| Genetic Variation | 4 | 2025 | 1556 | 0.260 |
Why?
|
| DNA | 2 | 2025 | 1419 | 0.250 |
Why?
|
| American Heart Association | 5 | 2020 | 324 | 0.240 |
Why?
|
| Bundle of His | 1 | 2026 | 15 | 0.240 |
Why?
|
| Diagnosis, Computer-Assisted | 2 | 2017 | 89 | 0.240 |
Why?
|
| Prospective Studies | 8 | 2025 | 6423 | 0.240 |
Why?
|
| Heart Septal Defects, Ventricular | 2 | 2020 | 135 | 0.230 |
Why?
|
| Survival Rate | 6 | 2021 | 2131 | 0.230 |
Why?
|
| Texas | 7 | 2019 | 3626 | 0.230 |
Why?
|
| Heart Atria | 3 | 2024 | 333 | 0.230 |
Why?
|
| Gene Deletion | 3 | 2018 | 769 | 0.230 |
Why?
|
| N-Terminal Acetyltransferase A | 1 | 2025 | 10 | 0.230 |
Why?
|
| N-Terminal Acetyltransferase E | 1 | 2025 | 11 | 0.230 |
Why?
|
| Amiodarone | 2 | 2024 | 47 | 0.230 |
Why?
|
| Cardiac Electrophysiology | 2 | 2016 | 15 | 0.220 |
Why?
|
| Mass Screening | 3 | 2017 | 805 | 0.220 |
Why?
|
| Adult | 18 | 2026 | 31127 | 0.220 |
Why?
|
| Tetracaine | 1 | 2024 | 11 | 0.220 |
Why?
|
| Electrocardiography, Ambulatory | 3 | 2024 | 61 | 0.210 |
Why?
|
| Tertiary Care Centers | 2 | 2017 | 249 | 0.210 |
Why?
|
| Medicine | 2 | 2022 | 100 | 0.200 |
Why?
|
| Risk Assessment | 6 | 2021 | 3682 | 0.190 |
Why?
|
| Hospital Mortality | 3 | 2022 | 1065 | 0.190 |
Why?
|
| Sequence Analysis, DNA | 2 | 2021 | 1723 | 0.190 |
Why?
|
| Heart Block | 1 | 2022 | 37 | 0.190 |
Why?
|
| Statistics, Nonparametric | 3 | 2016 | 426 | 0.190 |
Why?
|
| Brain Diseases, Metabolic | 1 | 2022 | 16 | 0.190 |
Why?
|
| Verapamil | 1 | 2022 | 47 | 0.180 |
Why?
|
| Atrial Flutter | 1 | 2022 | 45 | 0.180 |
Why?
|
| Siblings | 1 | 2023 | 202 | 0.180 |
Why?
|
| Vitamins | 1 | 2022 | 112 | 0.180 |
Why?
|
| Administration, Intravenous | 2 | 2023 | 168 | 0.180 |
Why?
|
| Isoproterenol | 1 | 2022 | 87 | 0.180 |
Why?
|
| Folic Acid | 1 | 2024 | 269 | 0.180 |
Why?
|
| Hypnotics and Sedatives | 2 | 2013 | 133 | 0.180 |
Why?
|
| Tachycardia, Ectopic Junctional | 1 | 2021 | 12 | 0.180 |
Why?
|
| Education, Distance | 1 | 2022 | 69 | 0.180 |
Why?
|
| Vesicular Transport Proteins | 1 | 2022 | 140 | 0.180 |
Why?
|
| Magnesium | 1 | 2022 | 114 | 0.180 |
Why?
|
| Induced Pluripotent Stem Cells | 1 | 2024 | 246 | 0.180 |
Why?
|
| Heart-Assist Devices | 2 | 2025 | 992 | 0.180 |
Why?
|
| Genotype | 3 | 2023 | 2605 | 0.180 |
Why?
|
| Canada | 4 | 2019 | 322 | 0.170 |
Why?
|
| Neuroimaging | 1 | 2025 | 389 | 0.170 |
Why?
|
| Acute Disease | 3 | 2023 | 1151 | 0.170 |
Why?
|
| Adenosine | 1 | 2022 | 118 | 0.170 |
Why?
|
| Mitochondrial Proteins | 1 | 2022 | 278 | 0.170 |
Why?
|
| Consensus | 3 | 2020 | 530 | 0.170 |
Why?
|
| Heart Ventricles | 4 | 2024 | 757 | 0.170 |
Why?
|
| Facies | 1 | 2021 | 157 | 0.170 |
Why?
|
| Coronary Vessel Anomalies | 2 | 2016 | 283 | 0.160 |
Why?
|
| Postoperative Complications | 5 | 2020 | 3112 | 0.160 |
Why?
|
| Prenatal Care | 1 | 2022 | 341 | 0.160 |
Why?
|
| Dietary Supplements | 1 | 2023 | 448 | 0.150 |
Why?
|
| Stroke Volume | 3 | 2026 | 531 | 0.150 |
Why?
|
| Secondary Prevention | 1 | 2021 | 219 | 0.150 |
Why?
|
| Primary Prevention | 1 | 2021 | 177 | 0.150 |
Why?
|
| Isolated Noncompaction of the Ventricular Myocardium | 1 | 2019 | 45 | 0.150 |
Why?
|
| Cardiac Surgical Procedures | 3 | 2013 | 1152 | 0.150 |
Why?
|
| Aftercare | 1 | 2020 | 150 | 0.150 |
Why?
|
| Myopathies, Nemaline | 1 | 2018 | 6 | 0.150 |
Why?
|
| AMP-Activated Protein Kinases | 1 | 2020 | 170 | 0.140 |
Why?
|
| Ventricular Function, Right | 2 | 2026 | 125 | 0.140 |
Why?
|
| Prevalence | 1 | 2025 | 2685 | 0.140 |
Why?
|
| Registries | 1 | 2025 | 1605 | 0.140 |
Why?
|
| Genetic Diseases, Inborn | 1 | 2022 | 470 | 0.140 |
Why?
|
| Cohort Studies | 6 | 2020 | 5069 | 0.140 |
Why?
|
| Ebstein Anomaly | 1 | 2018 | 29 | 0.140 |
Why?
|
| Quality of Life | 2 | 2022 | 2071 | 0.140 |
Why?
|
| Heart Transplantation | 2 | 2023 | 824 | 0.140 |
Why?
|
| Prosthesis Failure | 1 | 2019 | 156 | 0.140 |
Why?
|
| Lung Transplantation | 1 | 2022 | 354 | 0.140 |
Why?
|
| Desmoplakins | 1 | 2017 | 12 | 0.130 |
Why?
|
| Cognition | 1 | 2023 | 812 | 0.130 |
Why?
|
| Anticoagulants | 1 | 2022 | 601 | 0.130 |
Why?
|
| Keratosis | 1 | 2017 | 18 | 0.130 |
Why?
|
| Arrhythmogenic Right Ventricular Dysplasia | 1 | 2017 | 19 | 0.130 |
Why?
|
| Catecholamines | 1 | 2017 | 50 | 0.130 |
Why?
|
| Age Factors | 5 | 2019 | 2835 | 0.130 |
Why?
|
| Heterotaxy Syndrome | 1 | 2017 | 63 | 0.130 |
Why?
|
| Sleep Deprivation | 1 | 2017 | 44 | 0.130 |
Why?
|
| Algorithms | 3 | 2020 | 1680 | 0.130 |
Why?
|
| Evidence-Based Medicine | 4 | 2020 | 646 | 0.130 |
Why?
|
| Troponin T | 1 | 2018 | 255 | 0.130 |
Why?
|
| Ventricular Dysfunction, Left | 1 | 2020 | 358 | 0.130 |
Why?
|
| Azithromycin | 1 | 2016 | 46 | 0.120 |
Why?
|
| Athletes | 1 | 2017 | 72 | 0.120 |
Why?
|
| Syndactyly | 1 | 2016 | 24 | 0.120 |
Why?
|
| Calcium Channels, L-Type | 1 | 2016 | 51 | 0.120 |
Why?
|
| Ventricular Outflow Obstruction | 1 | 2016 | 72 | 0.120 |
Why?
|
| Plasma Membrane Calcium-Transporting ATPases | 1 | 2015 | 16 | 0.120 |
Why?
|
| Tilt-Table Test | 1 | 2015 | 9 | 0.120 |
Why?
|
| Rhabdomyolysis | 1 | 2016 | 35 | 0.120 |
Why?
|
| Pulmonary Valve | 1 | 2016 | 87 | 0.120 |
Why?
|
| Hospitals, Pediatric | 2 | 2017 | 802 | 0.110 |
Why?
|
| Amino Acids | 1 | 2018 | 562 | 0.110 |
Why?
|
| Muscle Weakness | 1 | 2016 | 89 | 0.110 |
Why?
|
| Clinical Competence | 2 | 2013 | 1051 | 0.110 |
Why?
|
| Models, Cardiovascular | 1 | 2015 | 165 | 0.110 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2018 | 1616 | 0.110 |
Why?
|
| Community-Acquired Infections | 1 | 2016 | 251 | 0.110 |
Why?
|
| Digoxin | 1 | 2014 | 37 | 0.110 |
Why?
|
| Weightlessness Simulation | 1 | 2014 | 23 | 0.110 |
Why?
|
| Tachycardia, Reciprocating | 1 | 2014 | 3 | 0.110 |
Why?
|
| Sports | 2 | 2013 | 64 | 0.110 |
Why?
|
| Prostheses and Implants | 1 | 2016 | 147 | 0.110 |
Why?
|
| Stroke | 1 | 2022 | 1055 | 0.110 |
Why?
|
| Brugada Syndrome | 1 | 2014 | 13 | 0.100 |
Why?
|
| rho GTP-Binding Proteins | 1 | 2014 | 72 | 0.100 |
Why?
|
| Cryosurgery | 1 | 2014 | 51 | 0.100 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 1 | 2014 | 159 | 0.100 |
Why?
|
| Pediatrics | 2 | 2014 | 1244 | 0.100 |
Why?
|
| Sympathectomy | 1 | 2013 | 8 | 0.100 |
Why?
|
| Anesthetics, Dissociative | 1 | 2013 | 18 | 0.100 |
Why?
|
| Electrophysiological Phenomena | 1 | 2013 | 61 | 0.100 |
Why?
|
| Middle Aged | 8 | 2025 | 28383 | 0.100 |
Why?
|
| Electrophysiology | 1 | 2013 | 250 | 0.100 |
Why?
|
| Pulmonary Artery | 1 | 2016 | 437 | 0.100 |
Why?
|
| Australia | 1 | 2013 | 171 | 0.100 |
Why?
|
| Calcium | 2 | 2014 | 1027 | 0.100 |
Why?
|
| Radiography, Interventional | 1 | 2013 | 87 | 0.100 |
Why?
|
| Surgery, Computer-Assisted | 1 | 2013 | 69 | 0.100 |
Why?
|
| Prognosis | 3 | 2023 | 4894 | 0.090 |
Why?
|
| Confidence Intervals | 1 | 2013 | 269 | 0.090 |
Why?
|
| Recurrence | 2 | 2014 | 1482 | 0.090 |
Why?
|
| Dexmedetomidine | 1 | 2013 | 47 | 0.090 |
Why?
|
| Shock, Cardiogenic | 1 | 2014 | 172 | 0.090 |
Why?
|
| Coronary Vessels | 1 | 2016 | 523 | 0.090 |
Why?
|
| Autistic Disorder | 1 | 2016 | 395 | 0.090 |
Why?
|
| Databases as Topic | 2 | 2014 | 74 | 0.090 |
Why?
|
| Heart Valve Prosthesis Implantation | 1 | 2016 | 428 | 0.090 |
Why?
|
| Pre-Excitation Syndromes | 1 | 2011 | 3 | 0.090 |
Why?
|
| Sex Distribution | 2 | 2016 | 315 | 0.090 |
Why?
|
| Ventricular Dysfunction, Right | 1 | 2012 | 78 | 0.090 |
Why?
|
| Age Distribution | 2 | 2016 | 424 | 0.090 |
Why?
|
| Rhabdomyoma | 1 | 2011 | 15 | 0.090 |
Why?
|
| Myxoma | 1 | 2011 | 28 | 0.090 |
Why?
|
| Fibroma | 1 | 2011 | 29 | 0.090 |
Why?
|
| Societies, Medical | 1 | 2016 | 790 | 0.090 |
Why?
|
| Sinus of Valsalva | 1 | 2011 | 32 | 0.090 |
Why?
|
| Pericardium | 1 | 2012 | 103 | 0.080 |
Why?
|
| Mice | 7 | 2024 | 18188 | 0.080 |
Why?
|
| Accessory Atrioventricular Bundle | 1 | 2010 | 9 | 0.080 |
Why?
|
| Patient Selection | 3 | 2020 | 721 | 0.080 |
Why?
|
| Risk Adjustment | 2 | 2020 | 57 | 0.080 |
Why?
|
| Patient Compliance | 1 | 2013 | 465 | 0.080 |
Why?
|
| Pregnancy | 1 | 2022 | 7380 | 0.080 |
Why?
|
| Atrial Appendage | 1 | 2010 | 76 | 0.080 |
Why?
|
| Combined Modality Therapy | 1 | 2013 | 1233 | 0.080 |
Why?
|
| Hypoplastic Left Heart Syndrome | 1 | 2012 | 267 | 0.070 |
Why?
|
| Ketamine | 1 | 2013 | 229 | 0.070 |
Why?
|
| Emergency Service, Hospital | 1 | 2017 | 1205 | 0.070 |
Why?
|
| Syndrome | 2 | 2025 | 1160 | 0.070 |
Why?
|
| Fetal Diseases | 1 | 2011 | 445 | 0.070 |
Why?
|
| Decision Support Techniques | 2 | 2020 | 295 | 0.070 |
Why?
|
| Chorea | 1 | 2007 | 32 | 0.070 |
Why?
|
| Extracorporeal Membrane Oxygenation | 1 | 2014 | 675 | 0.060 |
Why?
|
| Multivariate Analysis | 3 | 2016 | 1377 | 0.060 |
Why?
|
| Animals | 7 | 2024 | 33892 | 0.060 |
Why?
|
| Insurance, Health | 1 | 2007 | 139 | 0.060 |
Why?
|
| Mutation, Missense | 2 | 2024 | 931 | 0.060 |
Why?
|
| Seasons | 1 | 2007 | 333 | 0.060 |
Why?
|
| Cardiovascular Diseases | 1 | 2018 | 2110 | 0.060 |
Why?
|
| DNA Mutational Analysis | 2 | 2018 | 788 | 0.060 |
Why?
|
| Homozygote | 2 | 2018 | 539 | 0.060 |
Why?
|
| Amidohydrolases | 1 | 2025 | 21 | 0.060 |
Why?
|
| United Kingdom | 1 | 2025 | 255 | 0.050 |
Why?
|
| Exons | 2 | 2018 | 764 | 0.050 |
Why?
|
| Device Removal | 2 | 2019 | 225 | 0.050 |
Why?
|
| Epilepsy, Generalized | 1 | 2024 | 61 | 0.050 |
Why?
|
| Autonomic Nervous System | 1 | 2023 | 48 | 0.050 |
Why?
|
| Electric Stimulation | 1 | 2024 | 240 | 0.050 |
Why?
|
| Action Potentials | 1 | 2026 | 465 | 0.050 |
Why?
|
| Structure-Activity Relationship | 1 | 2024 | 552 | 0.050 |
Why?
|
| Vitamin K | 1 | 2022 | 34 | 0.050 |
Why?
|
| Vitamin A | 1 | 2022 | 57 | 0.050 |
Why?
|
| California | 2 | 2013 | 127 | 0.050 |
Why?
|
| Longitudinal Studies | 2 | 2017 | 1485 | 0.050 |
Why?
|
| Receptors, Cell Surface | 1 | 2024 | 420 | 0.050 |
Why?
|
| Membrane Glycoproteins | 1 | 2024 | 410 | 0.050 |
Why?
|
| Proportional Hazards Models | 1 | 2025 | 1399 | 0.040 |
Why?
|
| Base Sequence | 2 | 2016 | 2767 | 0.040 |
Why?
|
| Parents | 2 | 2022 | 1103 | 0.040 |
Why?
|
| Cells, Cultured | 2 | 2017 | 2905 | 0.040 |
Why?
|
| Cardiac Catheterization | 2 | 2017 | 623 | 0.040 |
Why?
|
| LIM Domain Proteins | 1 | 2020 | 65 | 0.040 |
Why?
|
| Disease Models, Animal | 2 | 2024 | 4656 | 0.040 |
Why?
|
| Ankyrins | 1 | 2020 | 96 | 0.040 |
Why?
|
| Czech Republic | 1 | 2019 | 11 | 0.040 |
Why?
|
| Self Report | 1 | 2022 | 555 | 0.040 |
Why?
|
| Cytoskeletal Proteins | 1 | 2020 | 267 | 0.040 |
Why?
|
| Comorbidity | 2 | 2016 | 1587 | 0.040 |
Why?
|
| Aged | 3 | 2024 | 20894 | 0.040 |
Why?
|
| Hospitals | 1 | 2021 | 439 | 0.030 |
Why?
|
| Health Personnel | 1 | 2022 | 548 | 0.030 |
Why?
|
| Surveys and Questionnaires | 2 | 2022 | 4002 | 0.030 |
Why?
|
| Antigens | 1 | 2017 | 104 | 0.030 |
Why?
|
| Proteoglycans | 1 | 2017 | 78 | 0.030 |
Why?
|
| Calsequestrin | 1 | 2017 | 12 | 0.030 |
Why?
|
| Keratinocytes | 1 | 2017 | 73 | 0.030 |
Why?
|
| Heart Diseases | 2 | 2012 | 501 | 0.030 |
Why?
|
| Fetus | 1 | 2020 | 572 | 0.030 |
Why?
|
| Telemetry | 1 | 2016 | 22 | 0.030 |
Why?
|
| Homeodomain Proteins | 1 | 2020 | 568 | 0.030 |
Why?
|
| Practice Patterns, Physicians' | 2 | 2014 | 771 | 0.030 |
Why?
|
| Patient Discharge | 1 | 2020 | 509 | 0.030 |
Why?
|
| Prosthesis Design | 1 | 2019 | 613 | 0.030 |
Why?
|
| Arabs | 1 | 2016 | 29 | 0.030 |
Why?
|
| Cephalosporins | 1 | 2016 | 136 | 0.030 |
Why?
|
| Penicillins | 1 | 2016 | 153 | 0.030 |
Why?
|
| Pneumonia, Bacterial | 1 | 2016 | 79 | 0.030 |
Why?
|
| Causality | 1 | 2016 | 90 | 0.030 |
Why?
|
| Golgi Apparatus | 1 | 2016 | 93 | 0.030 |
Why?
|
| International Cooperation | 1 | 2016 | 156 | 0.030 |
Why?
|
| Genetic Markers | 1 | 2017 | 597 | 0.030 |
Why?
|
| Sodium Channels | 1 | 2015 | 98 | 0.030 |
Why?
|
| Gene Frequency | 1 | 2017 | 739 | 0.030 |
Why?
|
| Endoplasmic Reticulum Stress | 1 | 2016 | 125 | 0.030 |
Why?
|
| Europe | 1 | 2016 | 366 | 0.030 |
Why?
|
| Rabbits | 1 | 2015 | 574 | 0.030 |
Why?
|
| Carrier Proteins | 1 | 2020 | 1006 | 0.030 |
Why?
|
| Animals, Genetically Modified | 1 | 2015 | 327 | 0.030 |
Why?
|
| Hindlimb Suspension | 1 | 2014 | 16 | 0.030 |
Why?
|
| Genomics | 1 | 2022 | 1619 | 0.030 |
Why?
|
| Databases, Genetic | 1 | 2017 | 507 | 0.030 |
Why?
|
| Sarcoplasmic Reticulum | 1 | 2014 | 148 | 0.030 |
Why?
|
| Ventricular Remodeling | 1 | 2014 | 154 | 0.030 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinase Type 2 | 1 | 2014 | 139 | 0.030 |
Why?
|
| Punctures | 1 | 2013 | 58 | 0.020 |
Why?
|
| Boston | 1 | 2013 | 118 | 0.020 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2025 | 3815 | 0.020 |
Why?
|
| Internationality | 1 | 2014 | 128 | 0.020 |
Why?
|
| Referral and Consultation | 1 | 2017 | 555 | 0.020 |
Why?
|
| Survival Analysis | 1 | 2016 | 1498 | 0.020 |
Why?
|
| Chromosome Mapping | 1 | 2015 | 1053 | 0.020 |
Why?
|
| Health Care Surveys | 1 | 2014 | 277 | 0.020 |
Why?
|
| Brain | 1 | 2025 | 3186 | 0.020 |
Why?
|
| Cardiopulmonary Resuscitation | 1 | 2016 | 320 | 0.020 |
Why?
|
| Pilot Projects | 1 | 2017 | 1452 | 0.020 |
Why?
|
| Patient Safety | 1 | 2017 | 442 | 0.020 |
Why?
|
| Muscle, Skeletal | 1 | 2018 | 1005 | 0.020 |
Why?
|
| Up-Regulation | 1 | 2014 | 833 | 0.020 |
Why?
|
| Echocardiography, Doppler | 1 | 2012 | 159 | 0.020 |
Why?
|
| DNA-Binding Proteins | 1 | 2020 | 1972 | 0.020 |
Why?
|
| Databases, Factual | 1 | 2016 | 1223 | 0.020 |
Why?
|
| Self Concept | 1 | 2012 | 157 | 0.020 |
Why?
|
| False Negative Reactions | 1 | 2011 | 87 | 0.020 |
Why?
|
| Lactic Acid | 1 | 2012 | 148 | 0.020 |
Why?
|
| Electrodes, Implanted | 1 | 2012 | 178 | 0.020 |
Why?
|
| Sensitivity and Specificity | 1 | 2016 | 2106 | 0.020 |
Why?
|
| False Positive Reactions | 1 | 2011 | 143 | 0.020 |
Why?
|
| Molecular Sequence Data | 1 | 2016 | 3507 | 0.020 |
Why?
|
| Animals, Newborn | 1 | 2014 | 1018 | 0.020 |
Why?
|
| Alleles | 1 | 2016 | 1685 | 0.020 |
Why?
|
| Myocardial Revascularization | 1 | 2011 | 100 | 0.020 |
Why?
|
| Phosphorylation | 1 | 2014 | 1577 | 0.020 |
Why?
|
| Chi-Square Distribution | 1 | 2012 | 561 | 0.020 |
Why?
|
| Sex Factors | 1 | 2014 | 1334 | 0.020 |
Why?
|
| Anesthesia | 1 | 2013 | 211 | 0.020 |
Why?
|
| Transcription Factors | 1 | 2020 | 2452 | 0.020 |
Why?
|
| Dissection | 1 | 2010 | 57 | 0.020 |
Why?
|
| Academic Medical Centers | 1 | 2012 | 318 | 0.020 |
Why?
|
| Equipment Design | 1 | 2012 | 541 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2016 | 2919 | 0.020 |
Why?
|
| Body Weight | 1 | 2013 | 984 | 0.020 |
Why?
|
| Odds Ratio | 1 | 2012 | 1215 | 0.020 |
Why?
|
| Genome, Human | 1 | 2015 | 1322 | 0.020 |
Why?
|
| Rats | 1 | 2014 | 3397 | 0.020 |
Why?
|
| Myocardial Ischemia | 1 | 2011 | 308 | 0.020 |
Why?
|
| Severity of Illness Index | 1 | 2016 | 3033 | 0.020 |
Why?
|
| Reoperation | 1 | 2011 | 832 | 0.020 |
Why?
|
| Diagnostic Errors | 1 | 2011 | 345 | 0.020 |
Why?
|
| Logistic Models | 1 | 2012 | 1799 | 0.020 |
Why?
|
| Mice, Knockout | 1 | 2014 | 3815 | 0.020 |
Why?
|
| Hypertension, Pulmonary | 1 | 2011 | 449 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 1 | 2014 | 4695 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2016 | 6781 | 0.010 |
Why?
|
| Cross-Sectional Studies | 1 | 2012 | 3803 | 0.010 |
Why?
|
| Biomarkers | 1 | 2012 | 3394 | 0.010 |
Why?
|
| Signal Transduction | 1 | 2014 | 4674 | 0.010 |
Why?
|